After a new round of centralized procurement, the price of coronary stents has decreased significantly! The price of drug-eluting stents has dropped from nearly ten thousand yuan to just over two thousand yuan.

After the sixth round of centralized procurement, the price of drug-coated balloon devices known as "hard currency" in the coronary artery field has dropped significantly. Prices of products from some winning companies have gone from over ten thousand yuan to the thousand yuan level, with the lowest price even below two thousand yuan. This also marks the entry of high-value coronary artery medical consumables into a "universal benefit era" following the stent era.